In a 66-year-old female with hypertension treated with losartan and amlodipine, who is status post internal hemipelvectomy and now has recurrent right thigh pain (pain score 10/10) with a diagnosis of recurrent chondrosarcoma of the right thigh, what is the appropriate diagnosis and management?

Recurrent Chondrosarcoma of the Right Thigh: Diagnosis and Management

This patient requires urgent multidisciplinary bone sarcoma MDT discussion, comprehensive staging with contrast-enhanced MRI and chest CT, followed by further wide surgical excision as the primary treatment for local recurrence 1.

Immediate Diagnostic Workup

Confirm Recurrence and Assess Extent

• Contrast-enhanced MRI of the right thigh to delineate tumor extent, assess for high-grade dedifferentiation, and evaluate surgical margins from prior hemipelvectomy
• Chest CT to rule out pulmonary metastases (most common site of distant spread)
• Biopsy if imaging suggests dedifferentiation or if histologic subtype needs clarification for treatment planning
• Baseline labs including renal function (creatinine) given prior pelvic surgery

Critical Pitfall

Pain score 10/10 in a patient with known chondrosarcoma should raise concern for either local recurrence (as stated) or pathological fracture, which significantly increases local recurrence risk and may necessitate amputation if wide margins cannot be achieved 1.

Management Algorithm

Primary Treatment: Surgical Resection

Local recurrence of chondrosarcoma is best treated by further wide excision 1. The surgical approach depends on:

1. If resectable with wide margins:

   • Proceed with wide surgical excision (goal: complete tumor removal with adequate margins)
   • For pelvic/axial tumors, 2 mm margins are associated with lower local recurrence rates 1
   • Surgery must be performed by bone sarcoma MDT surgeon at commissioned center 1

2. If unresectable or margins cannot be achieved:

   • Consider radiotherapy for unresectable disease or adjuvantly for close/positive margins 1
   • Particle therapy (proton beam or carbon ion) may allow dose escalation near critical structures 1
   • Amputation may be necessary if wide margins cannot be achieved, though this reduces local recurrence risk but doesn't improve survival due to high metastatic potential 1

Adjuvant/Systemic Therapy Considerations

Chemotherapy has extremely limited benefit in conventional chondrosarcoma 1. However:

• If mesenchymal subtype: Consider adjuvant/neoadjuvant chemotherapy 1
• If dedifferentiated subtype: Osteosarcoma-type chemotherapy protocols (doxorubicin/cisplatin) can be considered though prognosis remains poor 1
• For metastatic conventional chondrosarcoma: Pazopanib has demonstrated activity 1

Pain Management

With pain score 10/10, aggressive multimodal analgesia is essential:

• Opioid therapy titrated to effect
• Adjuvant neuropathic agents if nerve involvement
• Consider palliative radiotherapy if surgery delayed or not feasible
• Orthopedic consultation for pathological fracture risk assessment

Hypertension Management Considerations

Continue current antihypertensive regimen (losartan and amlodipine) during workup and treatment 2. These medications:

• Are appropriate for her age and cardiovascular risk profile
• Do not interfere with cancer treatment
• Losartan specifically has shown potential anti-tumor effects in preclinical osteosarcoma models (blocking CCL2-CCR2 monocyte recruitment) 3, though this is not established for chondrosarcoma treatment

Monitor blood pressure closely perioperatively and adjust as needed for surgical optimization.

Prognosis and Follow-up

Inoperable, locally advanced and metastatic chondrosarcomas have poor prognosis 1. Key prognostic factors include:

• Histological grade (high-grade worse)
• Axial/pelvic primary site (worse than extremity)
• Metastatic disease at presentation
• Ability to achieve wide surgical margins

If oligometastatic pulmonary disease develops, surgical metastatectomy or local ablation should be considered 1.

Critical Next Steps

1. Immediate bone sarcoma MDT referral (within 1 week)
2. Complete staging imaging (MRI thigh, CT chest) within 1 week
3. Pain control optimization immediately
4. Surgical planning once staging complete
5. Document histologic subtype from original pathology to guide systemic therapy decisions